https://www.lifescienceleader.com/doc/conduct-early-phase-studies-to-improve-manufacturability-and-mitigate-risk-0001
Conduct Early-Phase Studies To Improve Manufacturability And Mitigate Risk
While clinical efficacy is the critical benchmark for any drug program, ensuring manufacturability is also vital. An experienced CDMO can help you establish...
early phase studiesto improvemitigate riskconductmanufacturability
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-pharmacogenomics-premarket-evaluation-early-phase-clinical-studies-and-recommendations?source=govdelivery
Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations...
Clinical Pharmacology
early phase studiesclinicalpharmacogenomicspremarketevaluation